Table 2.
Trial/study | Author; journal; year | No. of patients | Parameter | Endpoint | Impact on HF hospitalisation |
---|---|---|---|---|---|
DOT-HF [16] |
Van Veldhuisen et al.; Circulation; 2011 |
335 | Intrathoracic impedance | HF hospitalisation | Increased |
OptiLink [14] |
Brachmann et al.; Eur J Heart Fail; 2011 |
1002 | Intrathoracic impedance | HF hospitalisation | Non-significant |
EFFECT [17] |
De Simone et al.; Europace; 2015 |
987 | Remote monitoring via ICD, or CRT | HF hospitalisation |
Reduced (IRR 0.54; 95% CI 0.24–0.62) |
MORE-CARE [13] |
Boriani et al.; Eur J Heart Fail; 2017 |
865 | Remote monitoring of advanced diagnostics via CRT‑D | HF hospitalisation | Non-significant |
REM-HF [15] |
Morgan et al.; Eur Heart J; 2017 |
1650 | Remote monitoring via ICD, or CRT | HF hospitalisation | Non-significant |
COMMIT-HF [18] |
Kurek et al.; J Cardiovasc Electrophysiol; 2017 |
574 | Remote monitoring via ICD, or CRT |
HF hospitalisation/ All-cause mortality |
Non-significant/ Reduced all-cause mortality (HR 0.24; 95% CI 0.14–0.41) |
IN-TIME [19] |
Hindricks et al; Lancet; 2014 |
716 | Remote monitoring via ICD, or CRT | HF worsening score | OR 0.63 95% Ci 0.43–0.90 |